Autolus Therapeutics Plc ADR (NQ: AUTL )
3.590
-0.160
(-4.27%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 14, 2024
Add to My Watchlist
All News about Autolus Therapeutics Plc ADR
![](https://g.foolcdn.com/editorial/images/712468/scientists-in-a-lab-monitor-microscope.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/09/image23.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 09, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/09/autl_logo_light__789443cb36be6ff9c202d747e31e41c2.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/09/image_3.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_9452.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/12/aapharma_10.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
![](https://ml.globenewswire.com/media/680b5e1a-9aba-4e38-b280-e43036561ef1/small/picture1-png.png)
Autolus Announces Pricing of Public Offering
December 08, 2022
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
December 08, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_173.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/680b5e1a-9aba-4e38-b280-e43036561ef1/small/picture1-png.png)
Autolus Announces Proposed Public Offering in the United States
December 08, 2022
Via GlobeNewswire
![](https://ml.globenewswire.com/media/680b5e1a-9aba-4e38-b280-e43036561ef1/small/picture1-png.png)
![](https://ml.globenewswire.com/media/680b5e1a-9aba-4e38-b280-e43036561ef1/small/picture1-png.png)
![](https://ml.globenewswire.com/media/680b5e1a-9aba-4e38-b280-e43036561ef1/small/picture1-png.png)
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 15, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/680b5e1a-9aba-4e38-b280-e43036561ef1/small/picture1-png.png)
![](https://ml.globenewswire.com/media/680b5e1a-9aba-4e38-b280-e43036561ef1/small/picture1-png.png)
![](https://ml.globenewswire.com/media/680b5e1a-9aba-4e38-b280-e43036561ef1/small/picture1-png.png)
![](https://ml.globenewswire.com/media/680b5e1a-9aba-4e38-b280-e43036561ef1/small/picture1-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_18464.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
R&D Efforts to Improve Optimal Treatments for Advanced Pancreatic Ductal Adenocarcinoma (PDAC) Progressing
October 05, 2022
Topics
Death
Exposures
Death
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_18416.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/04/image12.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/04/aapharma_4.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/680b5e1a-9aba-4e38-b280-e43036561ef1/small/picture1-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_17446.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/05/05/cells-gdd37bc5d2_1920.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.